Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Beverly › NPI 1316917941
Hospital

Northeast Hospital Corporation

Northeast Hospital Corporation was paid $68.00M by Medicaid between Jan 2018 and Dec 2024, across 438 billing codes. Its largest line is 99284, emergency room visit (serious) — 9.4% of everything it billed.

33Billing provider infoNORTHEAST HOSPITAL CORPORATION
BEVERLY, MA 01915
33aNPI1316917941assigned 01/25/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$68.00M
24GClaims2,294,376
24DCodes billed438
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in Massachusetts

Rank by total paid#1 of 27
Median peer was paid$138K
This provider vs. median494×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018341,190$11.29M
2019297,955$6.70M
2020289,371$7.46M
2021370,881$10.44M
2022368,365$11.82M
2023344,201$10.97M
2024incomplete282,413$9.32M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.4% 44,261 39,711 $6.41M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.3% 38,377 35,664 $5.63M
96361 Intravenous infusion, hydration; each additional hour 6.8% 13,338 11,732 $4.59M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.4% 27,190 24,063 $4.33M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4.5% 47,278 15,059 $3.05M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.4% 17,276 14,711 $2.31M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 3.2% 17,036 5,181 $2.20M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.6% 12,032 9,998 $1.77M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.6% 16,583 14,437 $1.75M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 9,624 8,841 $1.13M
G0378 Hospital observation service, per hour 1.6% 18,969 8,540 $1.10M
70450 Computed tomography, head or brain; without contrast material 1.6% 11,861 10,686 $1.08M
426 more codes
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.6% 7,024 $1.07M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 29,147 $1.02M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 6,885 $960K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.4% 40,992 $945K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.4% 31,976 $941K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 8,827 $939K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.4% 13,889 $925K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.3% 1,264 $875K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.2% 2,844 $787K
77063 Screening digital breast tomosynthesis, bilateral 1.1% 10,316 $778K
S9485 Crisis intervention mental health services, per diem 1.1% 1,490 $747K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.1% 4,325 $722K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,184 $643K
59025 Fetal non-stress test <1% 2,451 $617K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 22,081 $605K
99215 Doctor's office visit, returning patient (complex) <1% 4,514 $603K
71046 Radiologic examination, chest; 2 views <1% 21,757 $589K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 21,538 $587K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 930 $577K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,189 $514K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 3,146 $431K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 2,827 $423K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,548 $421K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,504 $403K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 98,674 $398K
87631 <1% 3,071 $349K
93971 <1% 2,743 $347K
97010 <1% 3,376 $345K
76770 <1% 2,885 $337K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 7,967 $329K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,956 $317K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,450 $309K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 11,074 $305K
84443 Thyroid stimulating hormone (TSH) <1% 33,490 $279K
80053 Comprehensive metabolic panel <1% 82,476 $275K
76642 <1% 2,868 $272K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 16,730 $263K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 11,587 $263K
97803 <1% 3,749 $248K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,184 $245K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 8,433 $223K
77067 Screening mammography, bilateral, including computer-aided detection <1% 10,560 $205K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,334 $203K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 9,675 $196K
84702 <1% 16,114 $191K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 9,939 $187K
97162 <1% 3,875 $180K
85027 <1% 48,290 $179K
96375 Therapeutic injection; each additional sequential IV push <1% 17,102 $178K
87086 Culture, bacterial; quantitative colony count, urine <1% 32,920 $172K
76536 <1% 1,528 $168K
83036 Hemoglobin; glycosylated (A1C) <1% 34,321 $157K
J3490 Unclassified drugs <1% 6,448 $148K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 3,087 $145K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 1,754 $145K
80050 General health panel <1% 9,469 $144K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,045 $143K
97161 <1% 3,409 $139K
86780 <1% 12,521 $137K
84484 <1% 19,591 $136K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 26,843 $131K
97535 Self-care/home management training, each 15 minutes <1% 2,454 $121K
ATP08 <1% 22,835 $118K
93017 <1% 1,559 $116K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 427 $115K
82607 <1% 14,213 $113K
80048 Basic metabolic panel (calcium, ionized) <1% 55,753 $111K
80061 Lipid panel <1% 41,779 $111K
86803 <1% 10,732 $111K
86480 <1% 2,288 $108K
82728 <1% 13,791 $107K
77065 Tomosynthesis, mammo <1% 1,457 $106K
93975 <1% 1,384 $106K
76830 Ultrasound, transvaginal <1% 1,348 $103K
73630 <1% 4,027 $101K
0001A <1% 3,969 $92K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 634 $90K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,739 $87K
J7030 Infusion, normal saline solution , 1000 cc <1% 29,507 $84K
84466 <1% 11,458 $83K
83880 <1% 7,304 $82K
90834 Psychotherapy session, about 45 minutes <1% 3,553 $81K
ATP14 <1% 15,529 $81K
12001 <1% 433 $80K
74018 <1% 2,145 $80K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 141 $79K
83690 <1% 17,815 $78K
87340 <1% 9,380 $76K
73610 <1% 3,059 $74K
87081 <1% 13,496 $73K
72100 <1% 2,340 $73K
ATP15 <1% 9,887 $73K
83735 <1% 21,209 $69K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 453 $68K
97802 <1% 890 $68K
86762 <1% 5,528 $68K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 3,356 $67K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 40,346 $65K
84153 <1% 4,907 $65K
71045 Radiologic examination, chest; single view <1% 12,054 $64K
71250 <1% 1,469 $64K
81003 <1% 47,982 $63K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 2,833 $62K
0002A <1% 2,094 $60K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 369 $58K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 947 $57K
77080 <1% 1,096 $56K
84439 <1% 10,791 $55K
85610 <1% 39,336 $55K
84403 <1% 3,367 $54K
83970 <1% 3,484 $54K
81025 <1% 9,508 $51K
73130 <1% 2,274 $49K
87186 <1% 10,148 $49K
87480 <1% 3,017 $49K
87510 <1% 3,016 $48K
87660 <1% 3,010 $48K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 228 $46K
82805 <1% 1,176 $45K
87077 <1% 9,683 $45K
J1756 Injection, iron sucrose, 1 mg <1% 711 $44K
86618 <1% 3,808 $44K
97116 <1% 2,289 $43K
83540 <1% 12,027 $43K
0011A <1% 1,205 $43K
87088 <1% 8,406 $42K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,720 $41K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,201 $41K
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,978 $41K
86850 <1% 6,027 $41K
88342 <1% 2,325 $40K
83516 <1% 2,156 $40K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,625 $40K
H0015 Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education <1% 241 $37K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 581 $37K
73030 <1% 2,231 $37K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,239 $36K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 24 $36K
87070 <1% 6,052 $35K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 453 $35K
86140 <1% 11,981 $35K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 2,042 $34K
71271 <1% 954 $34K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 118 $34K
ATP17 <1% 11,247 $34K
73110 <1% 1,462 $33K
84270 <1% 2,411 $32K
85379 <1% 5,104 $32K
82746 <1% 3,992 $32K
J7120 Ringers lactate infusion, up to 1000 cc <1% 10,178 $31K
87040 <1% 3,297 $30K
87147 <1% 4,813 $29K
77066 Tomosynthesis, mammo <1% 292 $28K
90715 <1% 1,438 $28K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 18,320 $27K
83001 <1% 1,935 $27K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 17,391 $26K
86787 <1% 2,377 $26K
73502 <1% 1,296 $25K
83021 <1% 1,635 $25K
72125 Computed tomography, cervical spine; without contrast material <1% 4,651 $25K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 372 $24K
82248 <1% 23,435 $24K
82784 <1% 3,122 $24K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 120 $24K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 706 $23K
82947 <1% 6,957 $22K
87522 Neg quan hep c or qual rna <1% 628 $22K
84146 <1% 1,547 $21K
93296 <1% 1,092 $21K
82043 <1% 8,437 $19K
83605 <1% 2,874 $19K
83020 <1% 1,687 $18K
90792 Psychiatric diagnostic evaluation with medical services <1% 361 $18K
85730 <1% 6,119 $18K
0012A <1% 528 $18K
86038 <1% 2,181 $17K
82570 <1% 6,211 $17K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,953 $16K
94060 <1% 229 $16K
J1815 Injection, insulin, per 5 units <1% 2,822 $16K
80076 <1% 5,820 $16K
96367 <1% 306 $16K
86900 <1% 6,016 $15K
91300 <1% 2,212 $15K
81514 <1% 158 $14K
73560 <1% 731 $14K
82550 <1% 3,726 $14K
88304 <1% 1,058 $13K
36415 Collection of venous blood by venipuncture <1% 88,983 $13K
86706 <1% 1,821 $13K
J1644 Injection, heparin sodium, per 1000 units <1% 4,868 $13K
87634 <1% 208 $12K
73140 <1% 507 $12K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 432 $12K
86901 <1% 6,009 $12K
86704 <1% 1,454 $12K
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,123 $12K
Q3014 Telehealth originating site facility fee <1% 5,026 $12K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,714 $12K
ATP03 <1% 4,845 $12K
76801 <1% 392 $11K
J2704 Injection, propofol, 10 mg <1% 14,425 $11K
82670 <1% 519 $11K
76819 Fetal biophysical profile; without non-stress testing <1% 336 $11K
85652 <1% 6,487 $11K
12011 <1% 66 $11K
82565 <1% 5,761 $11K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 9,353 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,967 $11K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 77 $11K
ATP16 <1% 1,685 $10K
87205 <1% 3,900 $10K
73564 <1% 1,032 $10K
82951 <1% 886 $10K
84156 <1% 4,079 $10K
ATP07 <1% 2,008 $9K
90832 Psychotherapy session, about 30 minutes <1% 1,395 $9K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 9,350 $9K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,746 $9K
85004 <1% 4,396 $8K
J0690 Injection, cefazolin sodium, 500 mg <1% 4,867 $8K
80164 <1% 2,097 $8K
70551 Magnetic resonance imaging, brain; without contrast material <1% 54 $8K
84550 <1% 8,325 $8K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 2,251 $7K
81329 <1% 57 $7K
94729 <1% 184 $7K
ATP05 <1% 997 $6K
97597 <1% 69 $6K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,048 $6K
86364 <1% 703 $6K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 4,928 $6K
84100 <1% 6,945 $6K
J0897 Injection, denosumab, 1 mg <1% 24 $6K
ATP11 <1% 1,916 $5K
86258 <1% 473 $5K
90791 Psychiatric diagnostic evaluation <1% 295 $5K
82105 <1% 364 $5K
J2060 Injection, lorazepam, 2 mg <1% 3,662 $5K
87625 <1% 212 $5K
83037 <1% 1,809 $5K
80178 <1% 1,616 $5K
99218 <1% 271 $5K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 43 $5K
84480 <1% 530 $5K
86141 <1% 546 $5K
ATP18 <1% 2,060 $5K
80159 <1% 764 $5K
82150 <1% 1,073 $4K
J3370 Injection, vancomycin hcl, 500 mg <1% 797 $4K
83002 <1% 321 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 299 $4K
84145 <1% 2,374 $4K
J7050 Infusion, normal saline solution, 250 cc <1% 397 $4K
84460 <1% 4,426 $4K
70486 <1% 101 $4K
97165 <1% 54 $4K
81508 <1% 113 $4K
88341 <1% 172 $4K
84450 <1% 4,275 $4K
70498 <1% 40 $3K
87150 <1% 406 $3K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 2,422 $3K
86431 <1% 704 $3K
85014 <1% 2,117 $3K
76870 <1% 38 $3K
87427 <1% 237 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 9,116 $3K
85018 <1% 1,948 $3K
80179 <1% 234 $3K
84520 <1% 4,080 $3K
74183 <1% 13 $3K
ATP10 <1% 1,023 $3K
82952 <1% 732 $2K
82077 <1% 774 $2K
86696 <1% 106 $2K
97163 <1% 43 $2K
82962 <1% 20,420 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 532 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,999 $2K
86695 <1% 118 $2K
12002 <1% 14 $2K
ATP04 <1% 436 $2K
87046 <1% 239 $2K
74019 <1% 133 $2K
87420 <1% 167 $2K
ATP09 <1% 302 $2K
87449 <1% 289 $2K
86160 <1% 90 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 40 $1K
84165 <1% 331 $1K
70496 <1% 30 $1K
86308 <1% 353 $1K
84163 <1% 92 $1K
87045 <1% 222 $1K
83520 <1% 114 $1K
90686 <1% 203 $1K
72141 <1% 12 $1K
36591 <1% 389 $1K
83921 <1% 82 $1K
87536 <1% 38 $1K
73080 <1% 95 $1K
71101 <1% 115 $1K
84681 <1% 77 $1K
87210 <1% 313 $1K
98968 <1% 13 $1K
84425 <1% 67 $1K
86360 <1% 111 $1K
82677 <1% 54 $1K
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 707 $1K
97035 <1% 20 $1K
84436 <1% 304 $1K
82533 <1% 80 $1K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 16,384 $1K
84134 <1% 105 $1K
87015 <1% 181 $998.21
86355 <1% 124 $967.80
83721 <1% 234 $957.09
87272 <1% 110 $953.62
87269 <1% 98 $916.99
72050 <1% 26 $889.73
86336 <1% 54 $888.16
87102 <1% 145 $886.38
86359 <1% 111 $864.54
86357 <1% 111 $864.54
73590 <1% 62 $829.59
87324 <1% 166 $825.22
83655 <1% 70 $824.52
ATP02 <1% 318 $808.61
99442 <1% 138 $801.66
86200 <1% 75 $776.81
70491 <1% 13 $762.22
80069 <1% 877 $762.15
J0780 Injection, prochlorperazine, up to 10 mg <1% 114 $729.41
86769 <1% 26 $702.42
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 4,081 $694.54
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 412 $686.14
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 589 $673.92
82390 <1% 83 $619.28
G0008 Administration of influenza virus vaccine <1% 351 $605.68
88307 <1% 39 $555.18
84481 <1% 39 $537.84
83090 <1% 37 $517.11
36000 <1% 52 $511.32
85045 <1% 247 $489.04
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 2,239 $474.25
82140 <1% 145 $466.65
83718 <1% 81 $460.47
97166 <1% 16 $457.12
11721 <1% 24 $426.76
86677 <1% 45 $420.69
84630 <1% 51 $417.73
86665 <1% 13 $416.00
72072 <1% 13 $413.91
83615 <1% 768 $375.04
82272 <1% 263 $374.09
82948 <1% 108 $368.52
86376 <1% 43 $362.94
86666 <1% 18 $359.36
A4217 Sterile water/saline, 500 ml <1% 69 $343.07
87641 <1% 44 $340.42
J1630 Injection, haloperidol, up to 5 mg <1% 215 $339.64
96376 <1% 3,141 $338.62
99443 <1% 43 $307.56
82610 <1% 24 $303.53
88112 <1% 12 $299.58
83883 <1% 43 $286.62
87640 <1% 44 $278.53
82270 <1% 189 $260.28
82247 <1% 68 $252.51
82040 <1% 421 $240.71
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 163 $229.43
84590 <1% 28 $227.60
86708 <1% 24 $206.95
A9585 Injection, gadobutrol, 0.1 ml <1% 3,233 $197.33
80143 <1% 90 $197.28
93246 <1% 26 $193.50
86664 <1% 13 $188.86
90662 <1% 91 $162.18
73552 <1% 14 $148.85
84132 <1% 280 $144.59
82525 <1% 12 $131.40
82010 <1% 30 $109.90
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 30 $94.98
87207 <1% 21 $91.41
86709 <1% 13 $79.44
80156 <1% 14 $75.15
73660 <1% 14 $73.55
82378 <1% 14 $58.68
J3486 Injection, ziprasidone mesylate, 10 mg <1% 13 $46.30
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 3,087 $43.30
82310 <1% 26 $36.18
82977 <1% 17 $14.84
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 334 $8.46
99152 <1% 212 $5.22
99153 Mod sedat endo service >5yrs <1% 318 $4.17
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 220 $3.29
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 0% 2,780 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 4,819 $0.00
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 0% 766 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 149 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 274 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 1,558 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 0% 106 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 555 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 632 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 114 $0.00
76942 0% 12 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 44 $0.00
J1020 Injection, methylprednisolone acetate, 20 mg 0% 17 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 13 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 31 $0.00
36592 0% 47 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 75 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 629 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 81 $0.00
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 0% 85 $0.00
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes 0% 311 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 196 $0.00
91301 0% 1,177 $0.00
C1769 Guide wire 0% 161 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 82 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 15 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 29 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCORMIER, PHILIP (CEO)